EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Influence of HLA Class I and II Polymorphisms on COVID-19 Severity in a South Brazilian Population

Sergio Grava iD, Matheus Braga iD, Victor Hugo de Souza iD, Afonso Carrasco Pepineli iD, Aléia Harumi Uchibaba Yamanaka, Christiane Maria Ayo, Joana Maira Valentini Zacarias iD, Andréa Name Colado Simão, Larissa Danielle Bahls Pinto iD, Quirino Alves de Lima Neto, Jeane Eliete Laguila Visentainer iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26115341 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Sergio Grava und 10 weiteren Autor:innen. Beteiligte Einrichtung: Post-Graduation Program in Biosciences and Physiopathology, Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá 870…. Hauptthemen laut MEDLINE: COVID-19, Polymorphism, Genetic, HLA-DRB1 Chains, Histocompatibility Antigens Class I. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Laboratory of Immunogenetics.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The high variability of human leukocyte antigen (HLA) genes results in each molecule having distinct antigenic peptide binding capacities, potentially influencing the immune response to SARS-CoV-2. This study aimed to investigate associations between HLA class I (A, B) and class II (DRB1) polymorphisms and COVID-19 severity in a South Brazilian population, and to evaluate the binding affinity of alleles to viral peptides. A cross-sectional study included 503 unvaccinated patients with RT-qPCR-confirmed COVID-19: 145 non-severe, 129 severe, and 229 critical. HLA typing was performed using PCR-SSO and Luminex™ technology. The DRB1*11 allelic group was significantly associated with protection against severe and critical cases, while DRB1*15 was associated with increased risk; both remained significant after Bonferroni correction. Other allelic groups were associated with disease outcomes but lost significance after correction: B*49 and B*08 (risk); and B*37, B*50, and A*03 (protection). In silico analysis revealed that the DRB1*15 allele group showed a higher proportion of strong binders, mostly from non-structural proteins, while DRB1*11:01 binders, though fewer in number, were concentrated in the M protein. These results suggest functional differences in antigen presentation and reinforce the relevance of class II HLA, particularly DRB1, in modulating COVID-19 severity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Polymorphism, GeneticHLA-DRB1 ChainsHistocompatibility Antigens Class IHumansBrazilFemaleMaleMiddle AgedAdultSeverity of Illness IndexSARS-CoV-2Cross-Sectional StudiesAllelesAgedGenetic Predisposition to DiseaseYoung Adult

Stichwörter der Autor:innen

HLA-DR beta-chainscoronavirusgenetichistocompatibility antigen classesin silico modelpolymorphism

Substanzen

HLA-DRB1 ChainsHistocompatibility Antigens Class I

Autor:innen und Institutionen

  • Post-Graduation Program in Biosciences and Physiopathology, Department of Clinical Analysis and Biomedicine, State University of Maringá, Maringá 87020-900, PR, Brazil.
  • Laboratory of Immunogenetics, Department of Dermatological, Infectious and Parasitic Diseases, Faculty of Medicine of São José do Rio Preto, São José do Rio Preto 15090-000, SP, Brazil.
  • Department of Basic Chairs, Marília School of Medicine-FAMEMA, Marília 17519-030, SP, Brazil.
  • Department of Pathology, Clinical Analysis and Toxicology, State University of Londrina, Londrina 86038-350, PR, Brazil.
  • Immunogenetics Laboratory, Department of Basic Health Sciences, State University of Maringá, Maringá 87020-900, PR, Brazil.

ORCID-Profile: Sergio Grava, Matheus Braga, Victor Hugo de Souza, Afonso Carrasco Pepineli, Joana Maira Valentini Zacarias, Larissa Danielle Bahls Pinto, Jeane Eliete Laguila Visentainer

Förderung

  • Laboratory of Immunogenetics

Zitieren

APA

Grava, S., Braga, M., Souza, V. H., Pepineli, A. C., Yamanaka, A. H. U., Ayo, C. M., Zacarias, J. M. V., Simão, A. N. C., Pinto, L. D. B., Neto, Q. A. L., & Visentainer, J. E. L. (2025). Influence of HLA Class I and II Polymorphisms on COVID-19 Severity in a South Brazilian Population. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26115341

Vancouver

Grava S, Braga M, Souza VH, Pepineli AC, Yamanaka AHU, Ayo CM, et al. Influence of HLA Class I and II Polymorphisms on COVID-19 Severity in a South Brazilian Population. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26115341

BibTeX
@article{Grava2025,
  author = {Grava, Sergio and Braga, Matheus and Souza, Victor Hugo de and Pepineli, Afonso Carrasco and Yamanaka, Aléia Harumi Uchibaba and Ayo, Christiane Maria and Zacarias, Joana Maira Valentini and Simão, Andréa Name Colado and Pinto, Larissa Danielle Bahls and Neto, Quirino Alves de Lima and Visentainer, Jeane Eliete Laguila},
  title = {Influence of HLA Class I and II Polymorphisms on COVID-19 Severity in a South Brazilian Population},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26115341}
}
Kostenlos starten →